An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)

NCT07426419 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Dilated Cardiomyopathy (DCM)
BAG3 Mutation Associated Dilated Cardiomyopathy

Interventions

GENETIC: AFTX-201

Sponsor

Affinia Therapeutics